CD7 and hematologic disorder: Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 AllogeneicCAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies